ISGIO 2023
ISGIO 2023
Advertisement
Kerri FitzgeraldISGIO 2023 | January 23, 2024
While liver cancer is the third deadliest cancer in the world, there are still unmet needs regarding the disease.
Read More
Zachary BessetteISGIO 2023 | January 23, 2024
Dr. Vatche G. Agopian provided an overview of the neoadjuvant systemic therapy options for HCC at ISGIO 2023.
Zachary BessetteISGIO 2023 | January 23, 2024
While therapies such as anti-VEGF therapy have improved hepatocellular cancer care, do these approaches have a role in BTC?
Zachary BessetteISGIO 2023 | January 23, 2024
The BCLC stratifies HCC into 5 stages based on lesion, performance status, vascular invasion, and extrahepatic spread.
Advertisement
Advertisement
Advertisement
Latest News

April 24, 2024